Glycosaminoglycans,proteoglycans&glycoproteinsDENS
1. Glycosaminoglycans (GAGs)
Overview:
Structure: Long, unbranched heteropolysaccharide chains composed of repeating disaccharide units (acidic sugar + amino sugar).
Function: Provide structural support, hydration, and lubrication in the extracellular matrix (ECM). They act as molecular sieves, influencing the movement of materials through the ECM.
Location: Found in connective tissues, cartilage, synovial fluid, and other extracellular spaces.
Classification:
Chondroitin Sulfate: Most abundant; found in cartilage, tendons, and ligaments.
Keratan Sulfate: Found in the cornea and loose connective tissue.
Hyaluronic Acid: Acts as a lubricant and shock absorber in synovial fluid and the vitreous humor of the eye.
Dermatan Sulfate: Contributes to skin elasticity and resilience.
Heparin: Acts as an anticoagulant; found in mast cells.
Heparan Sulfate: Plays a role in cell signaling and interactions with growth factors.
Synthesis:
GAGs are synthesized in the Golgi apparatus by sequential addition of acidic and amino sugars from UDP-derivatives.
Sulfation occurs after monosaccharides are incorporated into the growing GAG chain.
Degradation:
GAGs are degraded in lysosomes by acid hydrolases. Deficiencies in these enzymes lead to mucopolysaccharidoses (MPS), a group of hereditary diseases characterized by the accumulation of partially degraded GAGs.
2. Proteoglycans
Overview:
Structure: GAGs covalently attached to a core protein, forming a "bottle brush" structure.
Function: Provide structural integrity to the ECM, act as signaling molecules, and regulate cell behavior.
Proteoglycan Monomers:
GAGs (except hyaluronic acid) are attached to core proteins via a trihexoside linker (galactose-galactose-xylose) bound to a serine residue.
Proteoglycan Aggregates:
Proteoglycan monomers associate with hyaluronic acid to form large aggregates, stabilized by link proteins.
Synthesis:
Core proteins are synthesized in the rough endoplasmic reticulum (RER) and glycosylated in the Golgi apparatus.
GAG chains are elongated by glycosyltransferases, and sulfate groups are added post-translationally.
3. Glycoproteins
Overview:
Structure: Proteins with short, branched oligosaccharide chains attached via N-glycosidic (asparagine) or O-glycosidic (serine/threonine) linkages.
Function: Involved in cell surface recognition, antigenicity, and as protective biologic lubricants.
Synthesis:
Glycoproteins are synthesized in the RER and Golgi apparatus.
N-linked glycoproteins: Oligosaccharides are synthesized on dolichol pyrophosphate and transferred to asparagine residues.
O-linked glycoproteins: Oligosaccharides are added directly to serine or threonine residues.
Degradation:
Glycoproteins are degraded in lysosomes by acid hydrolases. Deficiencies in these enzymes lead to oligosaccharidoses, rare genetic diseases characterized by the accumulation of partially degraded glycoproteins.
4. Clinical Significance
Mucopolysaccharidoses (MPS):
Hereditary diseases caused by deficiencies in lysosomal enzymes that degrade GAGs.
Examples: Hurler syndrome (α-L-iduronidase deficiency), Hunter syndrome (iduronate sulfatase deficiency), Sanfilippo syndrome (heparan sulfate degradation defects).
Symptoms: Skeletal abnormalities, mental retardation, and early death.
Treatment: Enzyme replacement therapy and bone marrow transplantation.
I-Cell Disease:
A rare lysosomal storage disorder caused by the inability to phosphorylate mannose residues, leading to incorrect targeting of lysosomal enzymes.
Symptoms: Skeletal abnormalities, restricted joint movement, and severe psychomotor impairment.
Oligosaccharidoses:
Rare genetic diseases caused by deficiencies in glycoprotein degradation enzymes.
Example: α-Mannosidosis (α-mannosidase deficiency), leading to the accumulation of mannose-rich oligosaccharides.